[Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
D000328:Adult; D000983:Antipyrine / Q000652:urine*; D001663:Bilirubin / Q000097:blood; D002220:Carbamazepine / Q000008:administration & dosage / Q000627:therapeutic use*; D003404:Creatinine / Q000652:urine; D004827:Epilepsy / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006801:Humans; D006900:Hydroxylation; D008099:Liver / Q000201:enzymology*; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014277:Trigeminal Neuralgia / Q000188:drug therapy / Q000378:metabolism
D002220:Carbamazepine; D010672:Phenytoin; D003404:Creatinine; D001663:Bilirubin; D000983:Antipyrine
Einfluss antikonvulsiver Behandlung auf den Arzneimittelabbau beim Menschen. Induktion des hydroxylierenden Eznymsystems der Leber durch Diphenylhydantoin und Carbamazepin